The WHO listed AstraZeneca and Oxford University’s vaccine for emergency use last month, widening access to the relatively inexpensive shot in the developing world.

More than a dozen European countries have suspended use of the vaccine this week amid concerns.

The European Medicines Agency (EMA), which will release its findings on Thursday, has said it was investigating reports of 30 cases of unusual blood disorders out of 5 million recipients of the AstraZeneca vaccine. In total, 45 million COVID shots have been delivered across the region.

The WHO said its Global Advisory Committee on Vaccine Safety is carefully assessing the latest available safety data for the AstraZeneca vaccine.

Kate O’Brien, director of WHO’s department of immunization, said that its panel was assessing whether adverse events such as blood clots were actually related to vaccination.

Source: Times of India